Skip to main content
Erschienen in: International Urology and Nephrology 7/2015

01.07.2015 | Nephrology - Original Paper

Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism

verfasst von: Wan-Chuan Tsai, Yu-Sen Peng, Yen-Ling Chiu, Hon-Yen Wu, Mei-Fen Pai, Shih-Ping Hsu, Ju-Yeh Yang, Kuei-Ting Tung, Hung-Yuan Chen

Erschienen in: International Urology and Nephrology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hypocalcemia is one of the common complications after parathyroidectomy (PTX). Severe hypocalcemia (SH) can lead to tetany, cardiac arrhythmia and even sudden death. However, predictors for the development of SH in patients with secondary hyperparathyroidism demonstrated in some small-scale studies with a limited sample size remain inconclusive.

Methods

A retrospective chart review of 420 consecutive dialysis patients who underwent PTX during a 12-year period was performed. We checked serum levels of calcium (Ca), phosphorus (P), alkaline phosphatase (ALP) and intact parathyroid hormone (iPTH) for three consecutive days postoperatively. SH was defined as the minimum values of serum calcium lower than 1.875 mmol/L (7.5 mg/dL) within 3 days after operation.

Results

The mean (±SD) age of our study population was 53 ± 12 years, and more than half (57 %) were female. SH occurred in 37 % of the patients after PTX. Using a multivariate stepwise logistic regression analysis, lower preoperative levels of Ca (odds ratio 0.69, 95 % CI 0.60–0.79, P < 0.001), higher preoperative levels of iPTH (odds ratio 1.04, 95 % CI 1.00–1.07, P = 0.048), P (odds ratio 2.43, 95 % CI 1.49–3.95, P < 0.001) and ALP (odds ratio 1.08, 95 % CI 1.05–1.11, P < 0.001) were found to be independent predictors of occurrence of SH following PTX.

Conclusions

The readily obtainable preoperative laboratory parameters including Ca, iPTH, P, and ALP will allow identification of a subgroup of patients who are at greater risk for the development of SH following PTX.
Literatur
1.
Zurück zum Zitat Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, Chang JF, Chen HY (2013) Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience. Blood Purif 36(2):116–121. doi:10.1159/000353415 PubMedCrossRef Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, Chang JF, Chen HY (2013) Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience. Blood Purif 36(2):116–121. doi:10.​1159/​000353415 PubMedCrossRef
3.
Zurück zum Zitat Sharma J, Raggi P, Kutner N, Bailey J, Zhang R, Huang Y, Herzog CA, Weber C (2012) Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg 214(4):400–407; discussion 407–408. doi:10.1016/j.jamcollsurg.2011.12.046 Sharma J, Raggi P, Kutner N, Bailey J, Zhang R, Huang Y, Herzog CA, Weber C (2012) Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg 214(4):400–407; discussion 407–408. doi:10.​1016/​j.​jamcollsurg.​2011.​12.​046
4.
Zurück zum Zitat Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70(2):114–119; discussion 119–120 Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70(2):114–119; discussion 119–120
6.
Zurück zum Zitat Strickland PL, Recabaren J (2002) Are preoperative serum calcium, parathyroid hormone, and adenoma weight predictive of postoperative hypocalcemia? Am Surg 68(12):1080–1082PubMed Strickland PL, Recabaren J (2002) Are preoperative serum calcium, parathyroid hormone, and adenoma weight predictive of postoperative hypocalcemia? Am Surg 68(12):1080–1082PubMed
7.
Zurück zum Zitat Viaene L, Evenepoel P, Bammens B, Claes K, Kuypers D, Vanrenterghem Y (2008) Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism. Nephron Clin Pract 110(2):c80–c85. doi:10.1159/000151722 PubMedCrossRef Viaene L, Evenepoel P, Bammens B, Claes K, Kuypers D, Vanrenterghem Y (2008) Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism. Nephron Clin Pract 110(2):c80–c85. doi:10.​1159/​000151722 PubMedCrossRef
8.
9.
Zurück zum Zitat Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84(4):654–660PubMedCrossRef Brasier AR, Nussbaum SR (1988) Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 84(4):654–660PubMedCrossRef
10.
Zurück zum Zitat Denda M, Finch J, Slatopolsky E (1996) Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28(4):596–602PubMedCrossRef Denda M, Finch J, Slatopolsky E (1996) Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28(4):596–602PubMedCrossRef
11.
Zurück zum Zitat Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2013) Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Intern Suppl 3(5):462–468. doi:10.1038/kisup.2013.96 CrossRef Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K (2013) Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Intern Suppl 3(5):462–468. doi:10.​1038/​kisup.​2013.​96 CrossRef
Metadaten
Titel
Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism
verfasst von
Wan-Chuan Tsai
Yu-Sen Peng
Yen-Ling Chiu
Hon-Yen Wu
Mei-Fen Pai
Shih-Ping Hsu
Ju-Yeh Yang
Kuei-Ting Tung
Hung-Yuan Chen
Publikationsdatum
01.07.2015
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 7/2015
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1016-y

Weitere Artikel der Ausgabe 7/2015

International Urology and Nephrology 7/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.